INTEGREON GLOBAL Appoints Michael Hays as New President

Integreon Global, a family of companies that ensures product integrity and protection through innovative materials, testing services, packaging and monitoring solutions, and contract manufacturing, announced today that Michael Hays has been named President, replacing Maurice Barakat, effective December 5, 2022.  Mr. Barakat will assume the role of Executive Chairman and CEO.

Mr. Hays’ new position is the culmination of several decades of leadership in the expandable polystyrene (EPS) industry, most recently as Vice President of Altor Solutions.  His career path included management roles in business development, finance, and overall enterprise strategy and board level involvement.

As a long-term employee and eventual Division General Manager, he was integral in the growth of his original company, Premier Industries, which was later consolidated with Foam Fabricators and eventually transformed into Altor Solutions.  Through each of these strategic phases, Mr. Hays’ expertise contributed to his teams winning numerous industry awards for clients in the technology, automotive, appliance, construction, and health care sectors.  These accolades culminated with Michael receiving the EPS industry’s prestigious “Lifetime Achievement Award” in 2022.

“Michael is a people-first leader who comes to Integreon Global with a strong track record of expansion, coupled with a reputation for building a world-class packaging manufacturing group.  Michael’s extensive management experience will help our business units accelerate their continuing development as a trusted partner of global manufacturers,” said Maurice Barakat.

“I am proud and honored to become a part of the highly successful Integreon Global family,” said Michael Hays. “This is a wonderful opportunity to both lead and to provide outstanding service to our clients. Integreon has a strong, growing, and diversified suite of business units whose purpose is to protect people and products. The company’s unique blend of skilled experts, advanced materials, and innovative technologies across the entire enterprise positions us perfectly to rise to the challenges of a global marketplace.”

The Integreon group of companies designs and manufactures polymeric foam beads, thermal packaging and monitoring solutions, and provides testing, contract development and manufacturing services.  Integreon operates in four end markets: Pharmaceuticals, life sciences, perishable foods, and foam processors. Each of Integreon’s companies offers custom-engineered solutions and testing services critical to the end-to-end protection and efficient manufacturing of customers’ products.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.